Collaborations

Agreement signed for immunoassay system

Published in Obesity and Diabetes Week, October 10th, 2005

Abbott and Axis-Shield plc announced an exclusive partnership for the Afinion system, an immunoassay instrument designed for use in physicians' office laboratories and hospital point-of-care settings.

Currently marketed outside the United States, the Afinion system offers tests for a variety of medical conditions. In July, the Afinion system and first test, hemoglobin A1c (HbA1c), which is used in monitoring glycemic control in patients with diabetes, received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Under the terms of the agreement, Abbott was appointed as exclusive distributor of the Afinion instrument and test cartridges...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2005-10-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry